Literature DB >> 25037313

Prognosis by tumor location in adults with intracranial ependymomas.

Eli T Sayegh1, Derick Aranda2, Joseph M Kim2, Taemin Oh1, Andrew T Parsa1, Michael C Oh3.   

Abstract

Intracranial ependymomas are rare tumors in adults. Thus, factors affecting prognosis are poorly understood. We performed a study to investigate whether tumor location is an important prognostic factor in adults who undergo surgery for intracranial ependymomas. PubMed was searched to identify studies that reported clinical outcomes in adult patients with intracranial ependymoma. Data were extracted for patient and tumor characteristics, extent of resection, progression-free survival (PFS), and overall survival (OS). Tumors were categorized as supratentorial or infratentorial and extraventricular or intraventricular. Presenting clinical features and tumor characteristics were tabulated. Kaplan-Meier and multivariate Cox regression survival analyses were performed to determine PFS and OS by tumor location. Extent of resection was also analyzed by tumor location. A total of 183 patients were included in the meta-analysis. Patients presented at a mean of 8.2months with a myriad of clinical features. The mean tumor size was 3.38 cm, and 19.3% of tumors were cystic. Supratentorial tumors were most commonly located in the frontal and parietal lobes, and infratentorial tumors in the fourth ventricle. Supratentorial tumors demonstrated significantly poorer PFS (p<0.001) and OS (p=0.003) than infratentorial tumors, despite a higher rate of gross total resection (GTR) for the supratentorial tumors (72.6% versus 42.1%). Extraventricular ependymomas displayed significantly poorer PFS than intraventricular ependymomas (p=0.009). In summary, supratentorial ependymomas have significantly poorer PFS and OS than their infratentorial counterparts, despite being more conducive to GTR, suggesting increased clinical aggressiveness. Extraventricular location is also associated with significantly poorer PFS than intraventricular location.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adults; Ependymoma; Intracranial; Prognosis; Survival; Tumor location

Mesh:

Year:  2014        PMID: 25037313      PMCID: PMC4474735          DOI: 10.1016/j.jocn.2014.05.011

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  51 in total

1.  Ependymoma: a follow-up study of 101 cases.

Authors:  S J Mork; A C Loken
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

2.  The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases.

Authors:  L Palma; P Celli; A Mariottini; A Zalaffi; G Schettini
Journal:  Childs Nerv Syst       Date:  2000-03       Impact factor: 1.475

3.  Spinal cord ependymoma: radical surgical resection and outcome.

Authors:  Fadi Hanbali; Daryl R Fourney; Eric Marmor; Dima Suki; Laurence D Rhines; Jeffrey S Weinberg; Ian E McCutcheon; Ian Suk; Ziya L Gokaslan
Journal:  Neurosurgery       Date:  2002-11       Impact factor: 4.654

4.  Intracranial ependymomas: an analysis of prognostic factors and patterns of failure.

Authors:  Arnold C Paulino; B-Chen Wen; John M Buatti; David H Hussey; Weining K Zhen; Nina A Mayr; Arnold H Menezes
Journal:  Am J Clin Oncol       Date:  2002-04       Impact factor: 2.339

5.  A comparative study of ependymomas by site of origin.

Authors:  J E Marks; S J Adler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-01       Impact factor: 7.038

6.  Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.

Authors:  Phiroz E Tarapore; Peter Modera; Agne Naujokas; Michael C Oh; Beejal Amin; Tarik Tihan; Andrew T Parsa; Christopher P Ames; Dean Chou; Praveen V Mummaneni; Phillip R Weinstein
Journal:  Neurosurgery       Date:  2013-08       Impact factor: 4.654

7.  Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.

Authors:  Maura Massimino; Lorenza Gandola; Felice Giangaspero; Alessandro Sandri; Pinuccia Valagussa; Giorgio Perilongo; Maria Luisa Garrè; Umberto Ricardi; Marco Forni; Lorenzo Genitori; Giovanni Scarzello; Filippo Spreafico; Salvina Barra; Maurizio Mascarin; Bianca Pollo; Martina Gardiman; Armando Cama; Pierina Navarria; Maurizio Brisigotti; Paola Collini; Rita Balter; Paola Fidani; Maurizio Stefanelli; Roberta Burnelli; Paolo Potepan; Marta Podda; Guido Sotti; Enrico Madon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-04-01       Impact factor: 7.038

8.  Total removal of intramedullary ependymomas: follow-up study of 16 cases.

Authors:  G Fischer; L Mansuy
Journal:  Surg Neurol       Date:  1980-10

9.  Ependymomas of the spinal cord.

Authors:  R E Peschel; D S Kapp; F Cardinale; E E Manuelidis
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-07       Impact factor: 7.038

10.  Spinal ependymomas: prognostic factors and treatment results.

Authors:  Spyridon Voulgaris; George A Alexiou; Andreas Zigouris; George Fotakopoulos; Evaggelos Michos; Ioannis Katsiafas; George Savvanis; Dimitrios Pachatouridis
Journal:  J Cancer Res Ther       Date:  2013 Jan-Mar       Impact factor: 1.805

View more
  9 in total

Review 1.  Recent Advances in the Classification and Treatment of Ependymomas.

Authors:  Heather Leeper; Michelle M Felicella; Tobias Walbert
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

Review 2.  Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues.

Authors:  P D Delgado-López; E M Corrales-García; E Alonso-García; R García-Leal; R González-Rodrigálvarez; E Araus-Galdós; J Martín-Alonso
Journal:  Clin Transl Oncol       Date:  2019-03-13       Impact factor: 3.405

3.  Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.

Authors:  Roberta Rudà; Chiara Bosa; Michela Magistrello; Federica Franchino; Alessia Pellerino; Valentina Fiano; Morena Trevisan; Paola Cassoni; Riccardo Soffietti
Journal:  Neuro Oncol       Date:  2015-08-30       Impact factor: 12.300

4.  Analysis on therapeutic outcomes and prognostic factors of intracranial ependymoma: a report of 49 clinical cases in a single center.

Authors:  Jingliang Ye; Junle Zhu; Jiayi Yan; Peiqin Chen; Zhiping Wan; Feng Chen; Lei Zhang; Jun Qian; Chun Luo
Journal:  Neurol Sci       Date:  2015-07-28       Impact factor: 3.307

5.  Chemotherapy for intracranial ependymoma in adults.

Authors:  Dorothee Gramatzki; Patrick Roth; Jörg Felsberg; Silvia Hofer; Elisabeth J Rushing; Bettina Hentschel; Manfred Westphal; Dietmar Krex; Matthias Simon; Oliver Schnell; Wolfgang Wick; Guido Reifenberger; Michael Weller
Journal:  BMC Cancer       Date:  2016-04-23       Impact factor: 4.430

6.  Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC.

Authors:  Chia-Ying Lin; Chao-Chun Chang; Po-Lan Su; Chien-Chung Lin; Yau-Lin Tseng; Wu-Chou Su; Yi-Ting Yen
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study.

Authors:  Liguo Wang; Song Han; Changxiang Yan; Yakun Yang; Zhiqiang Li; Zuocheng Yang
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-02       Impact factor: 4.553

Review 8.  An Overview of Intracranial Ependymomas in Adults.

Authors:  Giuseppe Lombardi; Alessandro Della Puppa; Marco Pizzi; Giulia Cerretti; Camilla Bonaudo; Marina Paola Gardiman; Angelo Dipasquale; Fabiana Gregucci; Alice Esposito; Debora De Bartolo; Vittorina Zagonel; Matteo Simonelli; Alba Fiorentino; Francois Ducray
Journal:  Cancers (Basel)       Date:  2021-12-05       Impact factor: 6.639

9.  Microsurgical Resection of Brain Stem Ependymoma: 2-Dimensional Operative Video.

Authors:  Mirza Pojskić; Vincent Nguyen; Goran Lakičević; Kenan I Arnautović
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-06-01       Impact factor: 2.703

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.